-- Wedbush Securities周五发布的一份报告称，IBM（IBM）有望在下周三公布稳健的第一财季业绩，这主要得益于市场对人工智能、混合云、自动化和网络安全产品的持续需求。 报告指出，市场普遍预期IBM第一财季每股收益为1.81美元，营收为156.1亿美元，这一预期“有望超越”。 这家投资公司表示，IBM的“软件、咨询、基础设施和自动化组合构成了一个持久的业务飞轮”。该公司还成功地将软件、咨询和基础设施整合到一个统一的平台中，这是一个“重要的优势”。 报告还指出，随着市场对“智能体人工智能、关键任务型工作流程和受监管云采用”的兴趣日益浓厚，IBM在企业人工智能部署的下一阶段仍处于有利地位。 Wedbush重申了对IBM的“跑赢大盘”评级和340美元的目标价。
Price: $253.26, Change: $+2.26, Percent Change: +0.90%
Easou Technology (HKG:2550) said it has subscribed to a $7.7 million wealth management product issued by Huatai International Financial Products, using idle proceeds from its earlier placings, according to a Friday Hong Kong bourse filing.Shares of the digital service firm were down over 1% in Monday's late-morning trade.The investment, guaranteed by Huatai International Financial, carries an annualized return of 1.07% to 5.83% over a term ending March 30, 2027.Easou said the move aims to enhance the utilization efficiency and returns on idle funds while maintaining liquidity.
SSY Group (HKG:2005) said it received Chinese regulatory approval to begin drug production and registration of its diltiazem hydrochloride in injection form, according to a Hong Kong bourse filing Monday.The drug is mainly used to treat a heart condition known as supraventricular tachycardia and the emergency treatment of abnormally high blood pressure during surgery.The firm's propranolol hydrochloride injection was also approved for production and registration by China's National Medical Products Administration.The product is mainly used to treat supraventricular tachyarrhythmias and ventricular arrhythmias.
Amplitude Energy (ASX:AEL) said Australian Retirement Trust raised its stake in the firm to 6.3% as of Friday from 5.1% as of April 2, according to a Monday Australian bourse filing.Australian Retirement Trust now holds nearly 19 million votes in the firm.